Stockreport

Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology [Yahoo! Finance]

OREXO AB SP/ADR  (ORXOY) 
NASDAQ:AMEX Investor Relations: orexo.com/en/investors
PDF The AmorphOX technology is a powder made up of particles which are built using a unique combination of a drug, carrier materials and, optionally, other ingredients. The [Read more]